Repurposed Gi Drugs in the Treatment of COVID-19
Aguila, E.J.T.; Cua, I.H.Y.
Digestive Diseases and Sciences 65(8): 2452-2453
2020
ISSN/ISBN: 1573-2568
PMID: 32601778
DOI: 10.1007/s10620-020-06430-z
Accession: 072456903
PDF emailed within 0-6 h: $19.90
Related References
Martinez, M.A. 2021: Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment Frontiers in Immunology 12: 635371De, P.; Chakraborty, I.; Karna, B.; Mazumder, N. 2021: Brief review on repurposed drugs and vaccines for possible treatment of COVID-19 European Journal of Pharmacology 898: 173977
AlAjmi, M.F.; Azhar, A.; Owais, M.; Rashid, S.; Hasan, S.; Hussain, A.; Rehman, M.Tabish. 2020: Antiviral potential of some novel structural analogs of standard drugs repurposed for the treatment of COVID-19 Journal of Biomolecular Structure and Dynamics 2020: 1-13
Costa, B.ár.; Vale, N. 2021: A Review of Repurposed Cancer Drugs in Clinical Trials for Potential Treatment of COVID-19 Pharmaceutics 13(6)
Paul, S.S.; Biswas, G. 2021: Repurposed Antiviral Drugs for the Treatment of COVID-19: Syntheses, Mechanism of Infection and Clinical Trials Mini Reviews in Medicinal Chemistry 21(9): 1123-1143
Punekar, M.; Kshirsagar, M.; Tellapragada, C.; Patil, K. 2022: Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system Microbial Pathogenesis 168: 105608
Jang, W.D.; Jeon, S.; Kim, S.; Lee, S.Y. 2021: Drugs repurposed for COVID-19 by virtual screening of 6,218 drugs and cell-based assay Proceedings of the National Academy of Sciences of the United States of America 118(30)
Lem, F.F.; Opook, F.; Lee, D.J.H.; Chee, F.T.; Lawson, F.P.; Chin, S.N. 2020: Molecular Mechanism of Action of Repurposed Drugs and Traditional Chinese Medicine Used for the Treatment of Patients Infected with COVID-19: a Systematic Scoping Review Frontiers in Pharmacology 11: 585331
Na-Bangchang, K.; Porasuphatana, S.; Karbwang, J. 2022: Perspective: repurposed drugs for COVID-19 Archives of Medical Science: Ams 18(5): 1378-1391
Martinez, M.A. 2022: Efficacy of repurposed antiviral drugs: Lessons from COVID-19 Drug Discovery Today 27(7): 1954-1960
Chatterjee, B.; Thakur, S.S. 2022: Remdesivir and its Combination with Repurposed Drugs as COVID-19 Therapeutics Frontiers in Immunology 13: 830990
Aronskyy, I.; Masoudi-Sobhanzadeh, Y.; Cappuccio, A.; Zaslavsky, E. 2021: Advances in the computational landscape for repurposed drugs against COVID-19 Drug Discovery Today 26(12): 2800-2815
Khan, J.Z.; Ali, I.; Hassan, Z. 2020: Repurposed Drugs Against COVID-19: Safety Concerns and Stockout Hospital Pharmacy 55(4): 218-219
Hussain, I.; Hussain, A.; Alajmi, M.F.; Rehman, M.T.; Amir, S. 2021: Impact of repurposed drugs on the symptomatic COVID-19 patients Journal of Infection and Public Health 14(1): 24-38
Anwar, F.; Naqvi, S.; Al-Abbasi, F.A.; Neelofar, N.; Kumar, V.; Sahoo, A.; Kamal, M.A. 2021: Targeting COVID-19 in Parkinson's Patients: Drugs Repurposed Current Medicinal Chemistry 28(12): 2392-2408
Rubin, R. 2020: Study Aims to Identify Drugs that could be Repurposed for COVID-19 JAMA 324(20): 2019
Saul, S.; Einav, S. 2020: Old Drugs for a new Virus: Repurposed Approaches for Combating COVID-19 Acs Infectious Diseases 6(9): 2304-2318
Abuo-Rahma, G.E.-D.A.; Mohamed, M.F.A.; Ibrahim, T.S.; Shoman, M.E.; Samir, E.; Abd El-Baky, R.M. 2020: Potential repurposed SARS-CoV-2 (COVID-19) infection drugs RSC Advances 10(45): 26895-26916
Paul, M.; Kalil, A.C. 2021: Repurposed drugs for COVID-19: threshold and proof requirements for trials Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 27(12): 1716-1717
He, B.; Garmire, L. 2020: Prediction of repurposed drugs for treating lung injury in COVID-19 F1000research 9: 609